| Literature DB >> 24223406 |
Hidekazu Koike1, Hiroshi Matsui, Yasuyuki Morikawa, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki.
Abstract
PURPOSE: Inguinal hernias often occur after radical retropubic prostatectomy (RRP). We present a novel and simple technique for preventing inguinal hernias after RRP, which any surgeon can complete within a few minutes.Entities:
Keywords: Control and prevention; Inguinal hernia; Prostate neoplasms; Prostatectomy
Year: 2013 PMID: 24223406 PMCID: PMC3814116 DOI: 10.12954/PI.12009
Source DB: PubMed Journal: Prostate Int ISSN: 2287-8882
Fig. 1Our hernia prevention technique. (A) The right spermatic cord covered with the spermatic sheath. (B) The spermatic sheath is opened, and then approximately 5 cm of the vas deferens is released from the peritoneum. (C) Next, approximately 5 cm of the spermatic vessels are released from the peritoneum. (D) The thin section of tissue between the vas deferens and the spermatic vessels is removed. (E) In cases involving a thick processus vaginalis (or a processus vaginalis that protrudes into the abdomen), we ligate the processus vaginalis close to the peritoneal cavity and then transect it.
Patient characteristics
| Characteristic | Hernia prevention | Control | |
|---|---|---|---|
| Age at operation (yr) | 63.6±5.6 | 62.8±7.5 | NS |
| Follow-up period (mo) | 26.0±7.6 | 46.2±17.6 | <0.0001 |
| Initial PSA level (ng/mL) | 8.1±5.8 | 7.4±4.7 | NS |
| Clinical stage | |||
| T1 | 44 | 60 | |
| T2 | 68 | 55 | |
| T3 | 2 | 1 | NS |
| Gleason score | |||
| <7 | 4 | 15 | |
| 7 | 78 | 75 | |
| >7 | 33 | 25 | NS |
| Neoadjuvant hormonal therapy | 43/115 (37.4) | 35/115 (30.4) | NS |
| Nerve sparing | 22/115 (19.1) | 19/115 (16.5) | NS |
Values are presented as mean±standard deviation or number (%). PSA, prostate specific antigen; NS, not significant.
Fig. 2The Kaplan-Meier inguinal hernia-free rates after RRP of patients who did (prevention) or did not (control) undergo our hernia prevention procedure. The numbers on the curves indicate the number of patients at risk. Log-rank test of 2 samples (P<0.001).